Literature DB >> 22402938

Noncoding RNAs involved in mammary gland development and tumorigenesis: there's a long way to go.

Amy N Shore1, Jason I Herschkowitz, Jeffrey M Rosen.   

Abstract

The mammalian genome encodes thousands of noncoding RNAs. These noncoding transcripts are broadly categorized into short noncoding RNAs, such as microRNAs (miRNAs), and long noncoding RNAs (lncRNAs) of greater than 200 nt. While the role of miRNAs in development and cancer biology has been extensively studied, much less is known about the vast majority of noncoding transcripts represented by lncRNAs. LncRNAs are emerging as key regulators of developmental processes and as such, their frequent misregulation in tumorigenesis and disease in not unexpected. The role of lncRNAs in mammary gland development and breast cancer is just beginning to be elucidated. This review will discuss the role of lncRNAs in mammalian and mammary gland development. In addition, we will review the contributions of lncRNAs to the stepwise progression of tumorigenesis, highlighting the role of lncRNAs in breast cancer.

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22402938      PMCID： PMC3637027          DOI： 10.1007/s10911-012-9247-3

Source DB:  PubMed          Journal:  J Mammary Gland Biol Neoplasia        ISSN： 1083-3021            Impact factor:   2.673


  135 in total

Review 1.  Mammary development in the embryo and adult: a journey of morphogenesis and commitment.

Authors:  Christine J Watson; Walid T Khaled
Journal:  Development       Date:  2008-03       Impact factor: 6.868

2.  Long, abundantly expressed non-coding transcripts are altered in cancer.

Authors:  Damon S Perez; Tiffany R Hoage; Jay R Pritchett; Allison L Ducharme-Smith; Meredith L Halling; Sree C Ganapathiraju; Paul S Streng; David I Smith
Journal:  Hum Mol Genet       Date:  2007-11-15       Impact factor: 6.150

3.  Long noncoding RNAs in mouse embryonic stem cell pluripotency and differentiation.

Authors:  Marcel E Dinger; Paulo P Amaral; Tim R Mercer; Ken C Pang; Stephen J Bruce; Brooke B Gardiner; Marjan E Askarian-Amiri; Kelin Ru; Giulia Soldà; Cas Simons; Susan M Sunkin; Mark L Crowe; Sean M Grimmond; Andrew C Perkins; John S Mattick
Journal:  Genome Res       Date:  2008-06-18       Impact factor: 9.043

4.  Prostate cancer: diagnostic performance of the PCA3 urine test.

Authors:  George Leighton Lee; Albert Dobi; Shiv Srivastava
Journal:  Nat Rev Urol       Date:  2011-03       Impact factor: 14.432

5.  DAXX/ATRX, MEN1, and mTOR pathway genes are frequently altered in pancreatic neuroendocrine tumors.

Authors:  Yuchen Jiao; Chanjuan Shi; Barish H Edil; Roeland F de Wilde; David S Klimstra; Anirban Maitra; Richard D Schulick; Laura H Tang; Christopher L Wolfgang; Michael A Choti; Victor E Velculescu; Luis A Diaz; Bert Vogelstein; Kenneth W Kinzler; Ralph H Hruban; Nickolas Papadopoulos
Journal:  Science       Date:  2011-01-20       Impact factor: 47.728

6.  SNPs in ultraconserved elements and familial breast cancer risk.

Authors:  Rongxi Yang; Bernd Frank; Kari Hemminki; Claus R Bartram; Barbara Wappenschmidt; Christian Sutter; Marion Kiechle; Peter Bugert; Rita K Schmutzler; Norbert Arnold; Bernhard H F Weber; Dieter Niederacher; Alfons Meindl; Barbara Burwinkel
Journal:  Carcinogenesis       Date:  2008-01-03       Impact factor: 4.944

7.  The small-nucleolar RNAs commonly used for microRNA normalisation correlate with tumour pathology and prognosis.

Authors:  H E Gee; F M Buffa; C Camps; A Ramachandran; R Leek; M Taylor; M Patil; H Sheldon; G Betts; J Homer; C West; J Ragoussis; A L Harris
Journal:  Br J Cancer       Date:  2011-03-15       Impact factor: 7.640

8.  Induced ncRNAs allosterically modify RNA-binding proteins in cis to inhibit transcription.

Authors:  Xiangting Wang; Shigeki Arai; Xiaoyuan Song; Donna Reichart; Kun Du; Gabriel Pascual; Paul Tempst; Michael G Rosenfeld; Christopher K Glass; Riki Kurokawa
Journal:  Nature       Date:  2008-05-28       Impact factor: 49.962

9.  MicroRNA expression profiling of human breast cancer identifies new markers of tumor subtype.

Authors:  Cherie Blenkiron; Leonard D Goldstein; Natalie P Thorne; Inmaculada Spiteri; Suet-Feung Chin; Mark J Dunning; Nuno L Barbosa-Morais; Andrew E Teschendorff; Andrew R Green; Ian O Ellis; Simon Tavaré; Carlos Caldas; Eric A Miska
Journal:  Genome Biol       Date:  2007       Impact factor: 13.583

10.  Antisense transcripts are targets for activating small RNAs.

Authors:  Jacob C Schwartz; Scott T Younger; Ngoc-Bich Nguyen; Daniel B Hardy; Brett P Monia; David R Corey; Bethany A Janowski
Journal:  Nat Struct Mol Biol       Date:  2008-07-06       Impact factor: 15.369
View more
  25 in total

1.  Insights from Global Analyses of Long Noncoding RNAs in Breast Cancer.

Authors:  Andrew J Warburton; David N Boone
Journal:  Curr Pathobiol Rep       Date:  2017-01-23

2.  Long non-coding RNA CCAT1 that can be activated by c-Myc promotes pancreatic cancer cell proliferation and migration.

Authors:  Qiuyun Yu; Xinfeng Zhou; Qing Xia; Jia Shen; Jia Yan; Jiuting Zhu; Xiang Li; Ming Shu
Journal:  Am J Transl Res       Date:  2016-12-15       Impact factor: 4.060

3.  Long noncoding RNA PVT1 modulates thyroid cancer cell proliferation by recruiting EZH2 and regulating thyroid-stimulating hormone receptor (TSHR).

Authors:  Qinyi Zhou; Jun Chen; Jialin Feng; Jiadong Wang
Journal:  Tumour Biol       Date:  2015-10-01

Review 4.  Noncoding RNAs in breast cancer.

Authors:  Pang-Kuo Lo; Benjamin Wolfson; Xipeng Zhou; Nadire Duru; Ramkishore Gernapudi; Qun Zhou
Journal:  Brief Funct Genomics       Date:  2015-12-18       Impact factor: 4.241

5.  Mammary Tumor-Associated RNAs Impact Tumor Cell Proliferation, Invasion, and Migration.

Authors:  Sarah D Diermeier; Kung-Chi Chang; Susan M Freier; Junyan Song; Osama El Demerdash; Alexander Krasnitz; Frank Rigo; C Frank Bennett; David L Spector
Journal:  Cell Rep       Date:  2016-09-27       Impact factor: 9.423

Review 6.  Hormone-regulated transcriptomes: lessons learned from estrogen signaling pathways in breast cancer cells.

Authors:  Nasun Hah; W Lee Kraus
Journal:  Mol Cell Endocrinol       Date:  2013-06-28       Impact factor: 4.102

7.  Long non-coding RNA DUXAP8 promotes the cell proliferation, migration, and invasion of papillary thyroid carcinoma via miR-223-3p mediated regulation of CXCR4.

Authors:  Yan Liu; Hejia Zhang; Hui Wang; Jiarui Du; Peng Dong; Meihan Liu; Yuanqiang Lin
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

8.  The long noncoding RNA SPRY4-IT1 increases the proliferation of human breast cancer cells by upregulating ZNF703 expression.

Authors:  Yongguo Shi; Juan Li; Yangchen Liu; Jie Ding; Yingrui Fan; Yun Tian; Li Wang; Yifan Lian; Keming Wang; Yongqian Shu
Journal:  Mol Cancer       Date:  2015-02-22       Impact factor: 27.401

9.  Comparison of non-coding RNAs in human and canine cancer.

Authors:  Siegfried Wagner; Saskia Willenbrock; Ingo Nolte; Hugo Murua Escobar
Journal:  Front Genet       Date:  2013-04-08       Impact factor: 4.599

10.  A method for detecting long non-coding RNAs with tiled RNA expression microarrays.

Authors:  Sigrun Helga Lund; Daniel Fannar Gudbjartsson; Thorunn Rafnar; Asgeir Sigurdsson; Sigurjon Axel Gudjonsson; Julius Gudmundsson; Kari Stefansson; Gunnar Stefansson
Journal:  PLoS One       Date:  2014-06-17       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.